R1	Has_qualifier Arg1:T2 Arg2:T1	
R2	Has_qualifier Arg1:T4 Arg2:T3	
*	OR T5 T6
R3	Subsumes Arg1:T4 Arg2:T5	
*	OR T9 T10
R4	Has_negation Arg1:T13 Arg2:T12	
R5	AND Arg1:T11 Arg2:T13	
R6	Has_mood Arg1:T15 Arg2:T16	
R7	multi Arg1:T17 Arg2:T15	
R8	Has_qualifier Arg1:T14 Arg2:T17	
*	OR T18 T19
R9	Subsumes Arg1:T14 Arg2:T18	
R10	Has_qualifier Arg1:T25 Arg2:T24	
R11	AND Arg1:T27 Arg2:T26	
R12	Has_value Arg1:T26 Arg2:T28	
R13	Has_value Arg1:T29 Arg2:T30	
R14	Has_value Arg1:T31 Arg2:T32	
R15	Has_negation Arg1:T39 Arg2:T38	
R16	AND Arg1:T36 Arg2:T39	
*	OR T35 T36 T37
R17	Has_value Arg1:T41 Arg2:T42	
R18	Has_qualifier Arg1:T41 Arg2:T40	
R19	Has_value Arg1:T43 Arg2:T44	
R20	Subsumes Arg1:T53 Arg2:T54	
R21	Has_qualifier Arg1:T53 Arg2:T52	
*	OR T51 T53
R22	AND Arg1:T50 Arg2:T51	
*	OR T45 T50 T48 T47 T46 T49
*	OR T58 T59
R23	Has_negation Arg1:T58 Arg2:T57	
R24	AND Arg1:T56 Arg2:T58	
*	OR T56 T62 T63 T61
R25	Has_index Arg1:T64 Arg2:T65	
R26	Has_temporal Arg1:T56 Arg2:T64	
R27	AND Arg1:T67 Arg2:T68	
*	OR T69 T71 T70
R28	Subsumes Arg1:T68 Arg2:T69	
R29	AND Arg1:T73 Arg2:T74	
*	OR T75 T76 T77
*	OR T80 T81
R30	Has_multiplier Arg1:T87 Arg2:T88	
R31	Has_qualifier Arg1:T87 Arg2:T86	
R32	Subsumes Arg1:T85 Arg2:T87	
R33	Has_qualifier Arg1:T92 Arg2:T93	
*	OR T94 T95
R34	Subsumes Arg1:T92 Arg2:T94	
*	OR T112 T113
T1	Qualifier 0 9	Secondary
T2	Condition 10 29	knee osteoarthritis
T3	Qualifier 31 36	Other
T4	Condition 37 69	inflammatory Knee Osteoarthritis
T5	Condition 76 80	gout
T6	Condition 82 102	rheumatoid arthritis
T9	Condition 136 167	gastroesophageal reflux disease
T10	Condition 169 181	peptic ulcer
T11	Condition 184 205	Helicobacter infected
T12	Negation 224 227	not
T13	Procedure 233 256	treated for eradication
T14	Condition 319 339	Short bowel syndrome
T15	Condition 355 381	inflammatory bowel disease
T16	Mood 345 354	can cause
T17	Qualifier 340 381	that can cause inflammatory bowel disease
T18	Condition 383 401	ulcerative colitis
T19	Condition 403 418	Crohn's disease
T20	Condition 424 448	drug absorption disorder
T23	Condition 451 482	Intestinal obstruction syndrome
T24	Qualifier 484 495	Unexplained
T25	Condition 496 510	abdominal pain
T26	Measurement 512 547	ALT(Alanine aminotransferase) level
T27	Procedure 551 570	liver function test
T28	Value 571 606	exceeded 5 times of reference range
T29	Measurement 608 629	Total bilirubin level
T30	Value 630 648	exceeded 2 mg / dL
T31	Measurement 650 669	Serum albumin level
T32	Value 671 688	ess than 2 g / dL
T33	Condition 690 697	Ascites
T34	Condition 699 721	Hepatic encephalopathy
T35	Condition 723 734	Hepatitis B
T36	Condition 736 747	hepatitis C
T37	Condition 780 792	HIV positive
T38	Negation 749 758	excluding
T39	Condition 759 775	healthy carriers
T40	Qualifier 794 837	MDRD(Modification of Diet in Renal Disease)
T41	Measurement 838 874	Estimated Glomerular filtration rate
T42	Value 875 895	less than 60 mL / m2
T43	Condition 911 923	hyperkalemia
T44	Value 925 941	over 5.5 meq / L
T45	Condition 955 961	asthma
T46	Condition 963 977	acute rhinitis
T47	Condition 979 991	nasal polyps
T48	Condition 993 1003	angioedema
T49	Condition 1005 1014	urticaria
T50	Condition 1018 1036	allergic reactions
T51	Drug 1040 1047	aspirin
T52	Qualifier 1051 1056	other
T53	Drug 1057 1094	non-steroidal anti-inflammatory drugs
T54	Drug 1105 1121	COX-2 inhibitors
T56	Condition 1125 1141	Malignant tumors
T57	Negation 1142 1152	other than
T58	Condition 1153 1163;1181 1202	basal cell carcinoma of the skin
T59	Condition 1167 1202	squamous cell carcinoma of the skin
T61	Condition 1204 1243	CIN(Cervical Intraepitherial Neoplasia)
T62	Condition 1248 1284	CIS(Carcinoma in situ) of the cervix
T63	Condition 1290 1315	intraepithelial carcinoma
T64	Temporal 1331 1361	Within 5 years of consent date
T65	Reference_point 1349 1361	consent date
T67	Condition 1383 1399	hypersensitivity
T68	Drug 1407 1449	components of the investigational products
T69	Drug 1456 1481	components of test drug 1
T70	Drug 1456 1479;1486 1487	components of test drug 2
T71	Drug 1503 1519	Rhein-based drug
T73	Condition 1539 1556	allergic reaction
T74	Drug 1560 1571	sulfonamide
T75	Condition 1588 1609	galactose intolerance
T76	Condition 1611 1634	lapp lactase deficiency
T77	Condition 1638 1669	glucose-galactose malabsorption
T78	Non-representable 1672 1824	Subjects who have not reached the prescribed period after receiving contraindicated medication or treatment before participation in this clinical trial.
T79	Drug 1845 1871	contraindicated medication
T80	Condition 1874 1881;1897 1902	Alcohol abuse
T81	Condition 1892 1902	drug abuse
T82	Temporal 1918 1943	6 months before screening
T84	Pregnancy_considerations 1946 2021	Pregnant women or nursing mothers who are not willing to stop breastfeeding
T85	Condition 2028 2037	Menopause
T86	Qualifier 2039 2058	non-therapy-induced
T87	Condition 2059 2069	amenorrhea
T88	Multiplier 2073 2092	more than 12 months
T90	Person 2094 2100	Female
T91	Person 2106 2112	Female
T92	Condition 2113 2124	infertility
T93	Qualifier 2125 2139	due to surgery
T94	Condition 2141 2151	no ovaries
T95	Condition 2141 2143;2161 2167	no uterus
T98	Pregnancy_considerations 2174 2292	If you have sexual intercourse with only one male partner who has been confirmed to have no semen after fertilization.
T99	Pregnancy_considerations 2298 2371	Female subjects who agreed to abstinence during the clinical trial period
T100	Pregnancy_considerations 2374 2458	If the subject is assured of an abstinence throughout the trial period.(e.g. clergy)
T101	Pregnancy_considerations 2460 2611	However, intermittent abstinence (eg, contraception using ovulation period, symptothermal) or coitus interrupts is not a case of consent for abstinence
T104	Competing_trial 2989 3126	If 30 days have not elapsed after the date of signing of the previous clinical trial or currently participating in other clinical trials.
T105	Non-query-able 3128 3300	Patients who are scheduled for surgery during the clinical trial period or who have difficulties in completing the protocol during this clinical trial due to other reasons.
T106	Non-query-able 3302 3391	In addition to the above, other diseases that the investigator judges to be inappropriate
T102	Pregnancy_considerations 2614 2793	(5) For women of childbearing age, the following methods or methods of contraception use the effective method of contraception to be used during the period of this clinical trial:
T103	Drug 2795 2813	Oral contraceptive
T107	Device 2819 2838	contraceptive patch
T108	Device 2840 2866	Intra uterine device (IUD)
T109	Device 2868 2889	contraceptive implant
T110	Device 2891 2914	contraceptive injection
T111	Device 2916 2947	intrauterine hormonal apparatus
T112	Procedure 2949 2963	Tubal ligation
T113	Procedure 2968 2987	infertility surgery
